The effect of cholesteryl ester transfer protein-629C→A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides

被引:59
作者
Borggreve, SE [1 ]
Hillege, HL
Wolffenbuttel, BHR
de Jong, PE
Bakker, SJL
van der Steege, G
van Tol, A
Dullaart, RPF
机构
[1] Univ Groningen, Med Ctr, Dept Endocrinol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Med Ctr, Dept Cardiol, NL-9700 RB Groningen, Netherlands
[3] Univ Groningen, Med Ctr, Dept Nephrol, NL-9700 RB Groningen, Netherlands
[4] Univ Groningen, Med Ctr, Dept Clin Pharmacol, NL-9700 RB Groningen, Netherlands
[5] Univ Groningen, Med Ctr, Dept Internal Med, NL-9700 RB Groningen, Netherlands
[6] Univ Groningen, Med Ctr, Dept Genotyping Facil, NL-9700 RB Groningen, Netherlands
[7] Univ Groningen, Med Ctr, Dept Med Biol, NL-9700 RB Groningen, Netherlands
[8] Erasmus Univ, Med Ctr, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands
关键词
D O I
10.1210/jc.2005-0182
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: The -629C -> A cholesteryl ester transfer protein (CETP) promoter polymorphism is a determinant of HDL cholesterol (HDL-C). The effect of the closely linked CETP TaqIB polymorphism on HDL-C has been suggested to be modified by obesity and hyperinsulinemia. Objective: Because the CETP-mediated cholesteryl ester transfer out of HDL is stimulated by high triglycerides, we hypothesized that triglycerides modify the effect of the CETP-629C -> A promoter polymorphism on HDL-C. Design: In 7083 nondiabetic subjects of the PREVEND population, the -629C -> A promoter polymorphism, HDL-C, serum triglycerides, waist circumference, and insulin resistance (HOMA(ir)) were determined. Serum apolipoprotein A-I was available in 6948 subjects. The TaqIB polymorphism was also assessed. Setting: The study is set in the general community. Results: HDL-C and serum apolipoprotein A-I were on average 0.14 mmol/liter and 0.05 g/liter higher in -629AA ( 22.9%) compared to -629CC (26.8%) homozygotes ( P < 0.001 for both). This genotype effect on HDL-C was on average 0.15 mmol/liter in the lowest triglyceride tertile but only 0.08 mmol/liter in the highest tertile ( P < 0.01). Multiple regression analysis showed that HDL-C was determined by the CETP promoter variant ( P < 0.001), gender ( P < 0.001), triglycerides ( P < 0.001), and interactions between triglycerides and genotype ( P < 0.05), between triglycerides and gender ( P < 0.05), and between genotype and gender ( P < 0.05), independently from waist, HOMAir, alcohol use, age, and use of lipid-lowering drugs. The TaqIB polymorphism also interacted with triglycerides on HDL-C. The -629C -> A promoter polymorphism did not interact with obesity and HOMAir on HDL-C. Conclusions: The HDL-C-raising effect of the CETP-629A allele is diminished with higher triglycerides, which may be explained by a predominant effect of triglyceride-rich lipoproteins over circulating CETP itself on cholesteryl ester transfer out of HDL with rising triglycerides.
引用
收藏
页码:4198 / 4204
页数:7
相关论文
共 51 条
[31]   Heterogeneity at the CETP gene locus - Influence on plasma CETP concentrations and HDL cholesterol levels [J].
Kuivenhoven, JA ;
deKnijff, P ;
Boer, JMA ;
Smalheer, HA ;
Botma, GJ ;
Seidell, JC ;
Kastelein, JJP ;
Pritchard, PH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (03) :560-568
[32]   A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels - Interaction with the TaqIB and-629C/A polymorphisms [J].
Le Goff, W ;
Guerin, M ;
Nicaud, V ;
Dachet, C ;
Luc, G ;
Arveiler, D ;
Ruidavets, JB ;
Evans, A ;
Kee, F ;
Morrison, C ;
Chapman, MJ ;
Thillet, J .
ATHEROSCLEROSIS, 2002, 161 (02) :269-279
[33]   Haplotype analyses of cholesteryl ester transfer protein gene promoter:: a clue to an unsolved mystery of TaqIB polymorphism [J].
Lu, H ;
Inazu, A ;
Moriyama, Y ;
Higashikata, T ;
Kawashiri, M ;
Yu, WX ;
Huang, ZP ;
Okamura, T ;
Mabuchi, H .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (04) :246-255
[34]   MECHANISM OF PLASMA CHOLESTERYL ESTER TRANSFER IN HYPERTRIGLYCERIDEMIA [J].
MANN, CJ ;
YEN, FT ;
GRANT, AM ;
BIHAIN, BE .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :2059-2066
[35]   HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN [J].
MATTHEWS, DR ;
HOSKER, JP ;
RUDENSKI, AS ;
NAYLOR, BA ;
TREACHER, DF ;
TURNER, RC .
DIABETOLOGIA, 1985, 28 (07) :412-419
[36]   Plasma lipoproteins from patients with poorly controlled diabetes mellitus and ''in vitro'' glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo-B-containing lipoproteins [J].
Passarelli, M ;
Catanozi, S ;
Nakandakare, ER ;
Rocha, JC ;
Morton, RE ;
Shimabukuro, AFM ;
Quintao, ECR .
DIABETOLOGIA, 1997, 40 (09) :1085-1093
[37]  
Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882
[38]   Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein [J].
Riemens, S ;
van Tol, A ;
Sluiter, W ;
Dullaart, R .
ATHEROSCLEROSIS, 1998, 140 (01) :71-79
[39]   Relation of gemfibrozil treatment and lipid levels with major coronary events - VA-HIT: A randomized controlled trial [J].
Robins, SJ ;
Collins, D ;
Wittes, JT ;
Papademetriou, V ;
Deedwania, PC ;
Schaefer, EJ ;
McNamara, JR ;
Kashyap, ML ;
Hershman, JM ;
Wexler, LF ;
Rubins, HB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (12) :1585-1591
[40]  
Rothblat GH, 1999, J LIPID RES, V40, P781